[1984 revised guideline reported by the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure].
Nakashima
Y
Y
Arakawa
K
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D001581:Benzothiadiazines; D002986:Clinical Trials as Topic; D004232:Diuretics; D004334:Drug Administration Schedule; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D010349:Patient Compliance; D010817:Physician-Patient Relations; D012306:Risk; D012955:Societies, Medical / Q000458:organization & administration; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014481:United States
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors